03/08/2016
https://www.congress.gov...
"Members of this committee, most notably Senator Blunt, asked what NIH could do to ramp up innovation."
"I believe if there was open dialogue and a stronger partnership between NCATS and CTSAs, there would likely be more buy-in from the community."
"It appears to me that this change would bring uncertainty to the program and jeopardize the stability of the hubs."
"I mean, we know the impact in just the last half dozen years of immunotherapy on cancer treatment."